{"id":13516,"date":"2025-07-15T13:47:57","date_gmt":"2025-07-15T12:47:57","guid":{"rendered":"https:\/\/icoprevencio.cat\/uct\/aecc-cataluna-contra-el-cancer\/"},"modified":"2025-07-18T08:33:00","modified_gmt":"2025-07-18T07:33:00","slug":"aecc-cataluna-contra-el-cancer","status":"publish","type":"page","link":"https:\/\/icoprevencio.cat\/uct\/es\/aecc-cataluna-contra-el-cancer\/","title":{"rendered":"AECC Catalu\u00f1a contra el c\u00e1ncer"},"content":{"rendered":"\n<div class=\"wp-block-uagb-container uagb-block-709c37ea alignfull uagb-is-root-container\"><div class=\"uagb-container-inner-blocks-wrap\">\n<div class=\"wp-block-uagb-info-box uagb-block-353171f0 uagb-infobox__content-wrap  uagb-infobox-icon-above-title uagb-infobox-image-valign-top wp-block-uagb-info-box--has-margin\"><div class=\"uagb-infobox-margin-wrapper\"><div class=\"uagb-ifb-content\"><div class=\"uagb-ifb-title-wrap\"><h2 class=\"uagb-ifb-title\"><strong>Proyectos anteriores<\/strong><\/h2><\/div><\/div><\/div><\/div>\n<\/div><\/div>\n\n<div style=\"height:60px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<div class=\"wp-block-uagb-image uagb-block-71d5725e wp-block-uagb-image--layout-default wp-block-uagb-image--effect-static wp-block-uagb-image--align-none\"><figure class=\"wp-block-uagb-image__figure\"><img decoding=\"async\" src=\"https:\/\/icoprevencio.cat\/uct\/wp-content\/uploads\/sites\/10\/2024\/12\/AECC_logo-e1570087067939.jpg\" alt=\"\" class=\"uag-image-12108\" width=\"391\" height=\"92\" title=\"AECC_logo-e1570087067939\" loading=\"lazy\" role=\"img\"><\/figure><\/div>\n\n<div class=\"wp-block-uagb-info-box uagb-block-9271b190 uagb-infobox__content-wrap  uagb-infobox-icon-above-title uagb-infobox-image-valign-top wp-block-uagb-info-box--has-margin\"><div class=\"uagb-infobox-margin-wrapper\"><div class=\"uagb-ifb-content\"><div class=\"uagb-ifb-title-wrap\"><h3 class=\"uagb-ifb-title\">Coste-efectividad e impacto presupuestario de tres estrategias preventivas en c\u00e1ncer de pulm\u00f3n<\/h3><\/div><p class=\"uagb-ifb-desc\">La prevalencia de tabaquismo en Espa\u00f1a est\u00e1 disminuyendo; sin embargo, tanto la incidencia como la mortalidad por c\u00e1ncer de pulm\u00f3n est\u00e1n aumentando de forma alarmante entre las mujeres y se prev\u00e9 que la tendencia contin\u00fae en aumento si no se interviene. En un contexto general de contenci\u00f3n del gasto, las intervenciones sanitarias no s\u00f3lo deben ser evaluadas en t\u00e9rminos de impacto en salud o en t\u00e9rminos econ\u00f3micos, sino tambi\u00e9n en t\u00e9rminos de eficiencia. <\/p><\/div><\/div><\/div>\n<div class=\"wp-block-uagb-faq uagb-faq__outer-wrap uagb-block-07d58159 uagb-faq-icon-row-reverse uagb-faq-layout-accordion uagb-faq-expand-first-false uagb-faq-inactive-other-true uagb-faq__wrap uagb-buttons-layout-wrap uagb-faq-equal-height     \" data-faqtoggle=\"true\" role=\"tablist\"><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-24e60ec9 \" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\"><strong>Objetivos<\/strong><\/span><\/div><div class=\"uagb-faq-content\"><p>&#8211; Definir y estimar a la poblaci\u00f3n espa\u00f1ola con un alto riesgo de desarrollar un c\u00e1ncer de pulm\u00f3n.<br>&#8211; Determinar la proporci\u00f3n de poblaci\u00f3n atendida en Atenci\u00f3n Primaria con alto riesgo de desarrollar c\u00e1ncer de pulm\u00f3n.<br>&#8211; Realizar una evaluaci\u00f3n econ\u00f3mica comparando la implementaci\u00f3n de tres estrategias preventivas en c\u00e1ncer de pulm\u00f3n con un escenario de no intervenci\u00f3n, desde la perspectiva del sistema nacional de salud (SNS) y desde la perspectiva social. Se contempla un an\u00e1lisis de coste-utilidad para medir el beneficio en salud como a\u00f1os de vida ganados ajustados por calidad de vida, y un an\u00e1lisis de coste-efectividad para medir el beneficio en salud como muertes evitables por c\u00e1ncer de pulm\u00f3n. <br>&#8211; Analizar el impacto presupuestario de la implementaci\u00f3n de tres estrategias preventivas en c\u00e1ncer de pulm\u00f3n en el SNS.<br><\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-9be3fce9 \" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\"><strong>Metodolog\u00eda:<\/strong><\/span><\/div><div class=\"uagb-faq-content\"><p>Objetivo 1: Se utilizan los datos de la Encuesta Nacional de Salud de Espa\u00f1a (ENSE) 2011-12. Se describe la poblaci\u00f3n a riesgo en todo el territorio espa\u00f1ol y estratificado por sexo y por comunidad aut\u00f3noma. <br><br>Objetivo 2: Se explora la historia cl\u00ednica electr\u00f3nica de Atenci\u00f3n Primaria. Se selecciona la poblaci\u00f3n asignada y la poblaci\u00f3n atendida en la Regi\u00f3n Sanitaria de Barcelona considerando dos grupos de edad: 35-49 a\u00f1os (potencialmente a riesgo) y 50-75 a\u00f1os (alto riesgo). Se comparan los resultados con la proporci\u00f3n te\u00f3rica obtenida con ENSE y se calculan intervalos de confianza de proporciones para estimar diferencias estad\u00edsticamente significativas entre ambos grupos.  <br><br>Objetivo 3: Se estudia una cohorte hipot\u00e9tica con las caracter\u00edsticas de la poblaci\u00f3n adulta con alto riesgo de desarrollar un c\u00e1ncer de pulm\u00f3n y de la poblaci\u00f3n potencialmente a riesgo utilizando los datos de la ENSE 2011-12. y cribado organizado. Para determinar la eficacia de cada una de las intervenciones se realiza una revisi\u00f3n sistem\u00e1tica de la literatura para obtener diferentes porcentajes de abandono del consumo. Se compara el escenario basal (no intervenci\u00f3n) con tres estrategias preventivas, que combinan intervenciones de prevenci\u00f3n primaria y secundaria aplicadas a ambos grupos de poblaci\u00f3n.   <br><br>Objetivo 4: Se considera a la poblaci\u00f3n a riesgo calculada a partir de la ENSE 2011-12. Se estiman y comparan dos escenarios, el escenario actual y nuevos escenarios hipot\u00e9ticos derivados de la introducci\u00f3n de las distintas estrategias, contemplando distintos porcentajes de implementaci\u00f3n de las intervenciones. <\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-076be222 \" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\"><strong>Duraci\u00f3n<\/strong><\/span><\/div><div class=\"uagb-faq-content\"><p>1 a\u00f1o, prorrogado 6 meses (enero 2017 a junio 2018).<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-f17a63bd \" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\"><strong>Financiaci\u00f3n<\/strong><\/span><\/div><div class=\"uagb-faq-content\"><p>Ayudas para proyectos de investigaci\u00f3n en c\u00e1ncer, Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer (35.000\u20ac).<br><\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-43ba4076 \" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\"><strong>Equipo investigador<\/strong><\/span><\/div><div class=\"uagb-faq-content\"><p>Luc\u00eda Benito (ICO-IDIBELL)<br> Gemma Binefa (ICO-IDIBELL)<br> Misericordia Carlos (URV)<br> Julieta Corral (ICO-IDIBELL)<br> Mireia D\u00edaz (ICO-IDIBELL)<br> Esteve Fern\u00e1ndez (ICO-IDIBELL)<br> Marcela Fu (IP, ICO-IDIBELL)<br> Montse Garc\u00eda (IP, ICO-IDIBELL)<br> Carlos Mart\u00edn (CAP Paseo de San Juan)<br> Amparo Romaguera (ICO)<br> Albert Santiago (ICO-IDIBELL)<br> Carmen Vidal (ICO-IDIBELL)<br> Montserrat Ru\u00e9 (IRB Lleida)<br> Marta Trapero-Bertran (UIC)<br><\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-faa63e9c \" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\"><strong>Publicaciones cient\u00edficas<\/strong><\/span><\/div><div class=\"uagb-faq-content\"><p>1: Fu M, Travier N, Mart\u00edn-S\u00e1nchez JC, Mart\u00ednez-S\u00e1nchez JM, Vidal C, Garcia M; LUCAPREV research group. Identifying high-risk individuales para lung cancer screening: Going beyond NLST criteria. PLoS One. 2018;13(4):e0195441. doi: 10.1371\/journal.pone.0195441. PMID: 29621354; PMCID: PMC5886563.     <br><br>2: Travier N, Fu M, Romaguera A, Mart\u00edn Cantera C, Fern\u00e1ndez E, Vidal C, Garc\u00eda M; LUCAPREV research group. 6-Year Risk of Developing Lung Cancer in Spain: Analysis by Autonomous Communities. Arch Bronconeumol. 2021;57(8):521-7. doi: 10.1016\/j.arboles.2020.03.022. PMID: 32402549.     <br><br>3: Diaz M, Garc\u00eda M, Vidal C, Santiago A, Gnutti G, G\u00f3mez D, Trapero-Bertran M, Fu M; Lung Cancer Prevention LUCAPREV research group. Health and economic impact at a population level of both primary and secondary preventive lung cancer interventions: A modelo-based cost-effectiveness analysis. Lung Cancer. 2021;159:153-161. doi: 10.1016\/j.lungcan.2021.06.027. PMID: 34352591.     <br><br>Podcast publicaci\u00f3n Travier: https:\/\/multimedia.elsevier.es\/PublicationsMultimediaV1\/item\/multimedia\/stream\/S0300289620301034:mmc1.mp3?idApp=UINPBA00003Z<\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-3dabbcd9 \" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\"><strong><strong>Comunicaciones en congresos<\/strong><br><\/strong><\/span><\/div><div class=\"uagb-faq-content\"><p>Comunicaci\u00f3n p\u00f3ster: Santiago A, Fu M, Vidal C, Trapero M, Garcia M, D\u00edaz M. Modelo de simulaci\u00f3n matem\u00e1tica para evaluar estrategias de prevenci\u00f3n de c\u00e1ncer de pulm\u00f3n. Jornada I+D MESIO UPC-UB, 9 mayo 2018. <br><br>Comunicaci\u00f3n oral: Santiago-Bo\u00edl A, Fu M, Vidal C, Garc\u00eda M, D\u00edaz M. Coste-effectiveness analysis of lung cancer prevention strategies. XXXVIII Jornadas de Econom\u00eda de la Salud; Las Palmas de Gran Canaria, 20-22 junio 2018. <br><br>Comunicaci\u00f3n oral: Santiago-Bo\u00edl A, Fu M, Vidal C, Garc\u00eda M, D\u00edaz M. Coste-effectiveness analyses of lung cancer prevention strategies. XXIX International Biometric Conference; Barcelona, 8-13 julio 2018. <br><br>Comunicaci\u00f3n oral: Vidal C, Fu M, Travier N, Garc\u00eda M. Estratificaci\u00f3n del riesgo de c\u00e1ncer de pulm\u00f3n en la poblaci\u00f3n espa\u00f1ola. Implicaciones para la prevenci\u00f3n. XXXVI Reuni\u00f3n Anual de la Sociedad Espa\u00f1ola de Epidemiolog\u00eda (SEE) y XIII Congreso de la Associa\u00e7\u00e3o Portuguesa de Epidemiolog\u00eda (APE), Lisboa, 11-14 septiembre 2018.  <br><br>Comunicaci\u00f3n p\u00f3ster Garc\u00eda M, Fu M, Travier N, Vidal C. Identifiing high-risk individuales para el lung cancer screening\u2013going bey NELSON and NLST eligibility criteria. International Cancer Screening Network Conference, Rotterdam, 3-5 junio 2019. <br><br>Comunicaci\u00f3n oral: Garc\u00eda M, Vidal C, Santiago A, Fu M, Rue M, Carlos-Lavila M, Trapero-Bertran M, D\u00edaz M, Lung Cancer Prevention research group. A coste-effectiveness analysis of lung cancer prevention strategies en population level combining smoking cessation interventions and early detection with low-dose computed tomography in Spain. International Cancer Screening Conference, Rotterdam, 3-5 junio 2019.  <br><br>D\u00edaz M, Garc\u00eda M, Vidal C, Santiago A, Rue M, Carlos-Lavila M, Trapero-Bertran M, Fu M, Grupo de trabajo LUCAPREV. An\u00e1lisis de coste-efectividad de estrategias preventivas de c\u00e1ncer de pulm\u00f3n en Espa\u00f1a. XXXVII Reuni\u00f3n Anual de la Sociedad Espa\u00f1ola de Epidemiolog\u00eda (SEE), XIV Congreso de la Asociaci\u00f3n Portuguesa de Epidemiolog\u00eda (APE) y XVIII Congreso de la Sociedad Espa\u00f1ola de Sociedad Espa\u00f1ola de Salud P\u00fablica y Administraci\u00f3n Sanitaria (SESPAS), Oviedo, 3-6 septiembre 2019.  <\/p><\/div><\/div><div class=\"wp-block-uagb-faq-child uagb-faq-child__outer-wrap uagb-faq-item uagb-block-363ff10c \" role=\"tab\" tabindex=\"0\"><div class=\"uagb-faq-questions-button uagb-faq-questions\">\t\t\t<span class=\"uagb-icon uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t\t<svg xmlns=\"https:\/\/www.w3.org\/2000\/svg\" viewBox= \"0 0 448 512\"><path d=\"M432 256c0 17.69-14.33 32.01-32 32.01H256v144c0 17.69-14.33 31.99-32 31.99s-32-14.3-32-31.99v-144H48c-17.67 0-32-14.32-32-32.01s14.33-31.99 32-31.99H192v-144c0-17.69 14.33-32.01 32-32.01s32 14.32 32 32.01v144h144C417.7 224 432 238.3 432 256z\"><\/path><\/svg>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<span class=\"uagb-icon-active uagb-faq-icon-wrap\">\n\t\t\t\t\t\t\t<\/span>\n\t\t\t<span class=\"uagb-question\"><strong><strong><strong>Trabajo de Fin de M\u00e1ster<\/strong><br><\/strong><\/strong><\/span><\/div><div class=\"uagb-faq-content\"><p>T\u00edtulo: Lung Cancer Model for Evaluating Cancer Control Interventions.<br> Alumno: Albert Santiago Bo\u00edl.<br> Directora: Mireia D\u00edaz Sanchis.<br> Co-Director: Klaus Gerhard Langohr.<br> Programa: Master of Science in Advanced Mathematics and Mathematical Engineering<br> Centro: Departamento de Estad\u00edstica e Investigaci\u00f3n Operativa, UPC<br> Fecha de defensa: 16 mayo 2018\/2019.<\/p><\/div><\/div><\/div>\n<div style=\"height:131px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":28,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_vp_format_video_url":"","_vp_image_focal_point":[],"footnotes":""},"class_list":["post-13516","page","type-page","status-publish","hentry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"vp_sm":false,"vp_md":false,"vp_lg":false,"vp_xl":false,"vp_sm_popup":false,"vp_md_popup":false,"vp_xl_popup":false},"uagb_author_info":{"display_name":"clara","author_link":"https:\/\/icoprevencio.cat\/uct\/es\/author\/clara\/"},"uagb_comment_info":0,"uagb_excerpt":null,"_links":{"self":[{"href":"https:\/\/icoprevencio.cat\/uct\/es\/wp-json\/wp\/v2\/pages\/13516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/icoprevencio.cat\/uct\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/icoprevencio.cat\/uct\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/icoprevencio.cat\/uct\/es\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/icoprevencio.cat\/uct\/es\/wp-json\/wp\/v2\/comments?post=13516"}],"version-history":[{"count":3,"href":"https:\/\/icoprevencio.cat\/uct\/es\/wp-json\/wp\/v2\/pages\/13516\/revisions"}],"predecessor-version":[{"id":13944,"href":"https:\/\/icoprevencio.cat\/uct\/es\/wp-json\/wp\/v2\/pages\/13516\/revisions\/13944"}],"wp:attachment":[{"href":"https:\/\/icoprevencio.cat\/uct\/es\/wp-json\/wp\/v2\/media?parent=13516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}